Multicenter phase II study of lapatinib in patients with brain metastases from HER2-positive breast cancer.

Lin NU, DiГ©ras V, Paul D, Lossignol D, Christodoulou C, Stemmler HJ, RochГ© H, Liu MC, Greil R, Ciruelos E, Loibl S, Gori S, Wardley A, Yardley D, Brufsky A, Blum JL, Rubin SD, Dharan B, Steplewski K, Zembryki D, Oliva C, Roychowdhury D, et al.

http://www.ncbi.nlm.nih.gov/pubmed/19228746